# Regencell Bioscience Holdings Limited (RGC): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/rgc for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic
- Exchange: NASDAQ · Trading currency: USD

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $7.67 USD |
| Market Cap | $3.80B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.01 |
| 52-Week Range | $4.51 – $69.00 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 0.0% / 0.0% / 0.9% / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2018-02-15 | $0.2200 | 2018-02-26 |
| 2017-12-01 | $0.2200 | 2017-12-15 |
| 2017-08-31 | $0.2200 | 2017-09-15 |
| 2017-06-01 | $0.2200 | 2017-06-15 |
| 2017-03-01 | $0.2200 | 2017-03-15 |
| 2016-12-01 | $0.2200 | 2016-12-15 |
| 2016-08-31 | $0.2200 | 2016-09-15 |
| 2016-06-02 | $0.2200 | 2016-06-16 |
| 2016-03-02 | $0.2200 | 2016-03-15 |
| 2015-12-02 | $0.2200 | 2015-12-15 |
| 2015-09-02 | $0.2200 | 2015-09-15 |
| 2015-05-29 | $0.2200 | 2015-06-12 |

Full history: https://www.dividenddata.com/stocks/rgc/dividend

## Frequently Asked Questions

### What does Regencell Bioscience Holdings Limited do?

Regencell Bioscience Holdings Limited (RGC) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is RGC's market cap?

Regencell Bioscience Holdings Limited (RGC) has a market capitalization of approximately $3.80 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does RGC pay a dividend?

No, Regencell Bioscience Holdings Limited (RGC) is not currently paying a dividend. Its last ex-dividend date was February 15, 2018 ($0.22 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### Is RGC profitable?

Regencell Bioscience Holdings Limited (RGC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### How often did RGC pay dividends?

Regencell Bioscience Holdings Limited paid dividends quarterly until 2018; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is RGC's payout ratio?

Regencell Bioscience Holdings Limited's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/rgc
- Dividend history & safety: https://www.dividenddata.com/stocks/rgc/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/rgc/earnings
- Financial statements: https://www.dividenddata.com/stocks/rgc/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/rgc/valuation
- Peer comparison: https://www.dividenddata.com/stocks/rgc/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.